H
Hangzhou Yingshu Life Technology
Health Tech & Medtech · China · Founded 2021
A medical device enterprise specialized in the R&D, production and sales of high-end medical endoscope systems MoreLess
Endoso is a global professional manufacturer specializing in minimally invasive surgical devices. Established in Hunan and later expanding to Shenzhen and Hangzhou, the company operates within the medical device industry, focusing on advanced endoscopy systems. Endoso's core products include 4K ultra high definition fluorescence laparoscopes and thoracoscopes, as well as single-use endoscope solutions. The company serves healthcare providers and medical institutions, offering cutting-edge technology to enhance surgical precision and patient outcomes. Endoso's business model revolves around the development, manufacturing, and distribution of these high-tech medical devices, generating revenue through direct sales and partnerships with medical facilities. The company has achieved significant milestones, including obtaining major certifications such as EU CE, FDA, and NMPA approvals, which validate the quality and safety of its products. Endoso has also gained international recognition by participating in prominent medical exhibitions like the Arab Health and CMEF, showcasing its innovations on the global stage. The company continues to grow, driven by increasing market demand and a commitment to advancing medical technology.
Keywords: minimally invasive, surgical devices, 4K imaging, endoscopy, laparoscope, thoracoscope, single-use, medical technology, healthcare, certifications.
Company overview
Hangzhou Yingshu Life Technology company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2021
- Headquarters
- China
- Employees
- —
- Open positions
- None listed
- Dealroom signal
- 22.3
Valuation & funding
Hangzhou Yingshu Life Technology funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jan 2024 | $14M | $55M | Longpan Investment · Weigao Songyuan Fund | ↗ |
| EARLY VC✓Equity / VC | Nov 2022 | $2.8M | $11M | Vision Plus Capital · BGI Co-Win | ↗ |
Growth signals
Hangzhou Yingshu Life Technology website traffic
Latest recorded traffic for Hangzhou Yingshu Life Technology is 190 monthly website visits, down 64.8% over the last three months.
Comparisons
Hangzhou Yingshu Life Technology compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Hangzhou Yingshu Life Technology's talent
Source: Dealroom Talent Intelligence.
Investors
4 investors on Hangzhou Yingshu Life Technology's cap table
Sourced from Dealroom's funding and investor records.


Global footprint
Where Hangzhou Yingshu Life Technology has talent and traffic
In the news
Latest news about Hangzhou Yingshu Life Technology
Recent press, funding announcements, and product moves mentioning Hangzhou Yingshu Life Technology — open to read from the original sources.
Market sentiment
What the market is saying about Hangzhou Yingshu Life Technology
An AI-synthesized read of the highest-engagement posts about Hangzhou Yingshu Life Technology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hangzhou Yingshu Life Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.




